More on MGRX

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mangoceuticals (NQ:MGRX)
Delayed: 0.37 --0 (-0%)
Prev. Close $0.37  
Open$0.35 
52 Wk High$ 
52 Wk Low$ 
Day High$0.37 
Day Low$0.34 
P/E N/A  
EPS$ 
Volume22,435,195 

Friends, Peers and Foes (?): LLY NVO (more...)

Mar 6, 2026 04:00 PM Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
Feb 23, 2026 04:06 PM Form 8-K MANGOCEUTICALS, INC. For: Feb 23
Feb 23, 2026 04:05 PM Mangoceuticals reports zero respiratory deaths in 29,000-bird trials
Feb 23, 2026 04:05 PM Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
Feb 19, 2026 04:06 PM Form 8-K MANGOCEUTICALS, INC. For: Feb 19
Feb 19, 2026 04:06 PM MangoRx reports 336% monthly growth for $99 TRT program
Feb 19, 2026 04:05 PM MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Feb 6, 2026 04:31 PM Form 8-K MANGOCEUTICALS, INC. For: Feb 04
Jan 29, 2026 06:06 AM Form EFFECT MANGOCEUTICALS, INC.
Jan 23, 2026 05:08 PM Form S-1/A MANGOCEUTICALS, INC.
View All Articles

Entities mentioned with MGRX

View All Entities